Prostate cancer imaging has become an important diagnostic modality for tumor evaluation. Prostate-specific membrane antigen (PSMA) positron emission tomography (PET) has been extensively studied, and the results are robust and promising. The advent of the PET/magnetic resonance imaging (MRI) has added morphofunctional information from the standard of reference MRI to highly accurate molecular information from PET. Different PSMA ligands have been used for this purpose including 68gallium and 18fluorine-labeled PET probes, which have particular features including spatial resolution, imaging quality and tracer biodistribution. The use of PSMA PET imaging is well established for evaluating biochemical recurrence, even at low prostate-specific...
Positron emission tomography (PET) has been commonly and successfully used, in combination with comp...
IntroductionProstate-specific membrane antigen (PSMA) is increasingly being recognized as a novel ta...
Gallium-68 and Fluor-18 labeled prostate specific membrane antigen (PSMA) molecules have created new...
Prostate cancer imaging has become an important diagnostic modality for tumor evaluation. Prostate-s...
Prostate-specific membrane antigen (PSMA) is highly expressed on most prostate cancer (PCa) cells, a...
As precision medicine evolves, the contribution of molecular imaging to the management of prostate c...
Prostate cancer (PCa) is the most common malignancy in men worldwide, leading to substantial morbidi...
68Gallium prostate specific membrane antigen (PSMA) ligand positron emission tomography (PET) is an ...
Nowadays several new imaging modalities are available for investigating prostate cancer (PCa) such a...
Prostate-specific membrane antigen (PSMA) positron emission tomography/magnetic resonance imaging (P...
Abstract 68Gallium prostate specific membrane antigen (PSMA) ligand positron emission tomography (PE...
Imaging has a central role in the context of focal therapy (FT) for prostate cancer (PCa). Prostate-...
Positron emission tomography (PET) has been commonly and successfully used, in combination with comp...
OBJECTIVE: The purpose of this article is to describe the large number of radiotracers being evalu...
Prospective evidence for the clinical role and efficacy of prostate specific membrane antigen (PSMA)...
Positron emission tomography (PET) has been commonly and successfully used, in combination with comp...
IntroductionProstate-specific membrane antigen (PSMA) is increasingly being recognized as a novel ta...
Gallium-68 and Fluor-18 labeled prostate specific membrane antigen (PSMA) molecules have created new...
Prostate cancer imaging has become an important diagnostic modality for tumor evaluation. Prostate-s...
Prostate-specific membrane antigen (PSMA) is highly expressed on most prostate cancer (PCa) cells, a...
As precision medicine evolves, the contribution of molecular imaging to the management of prostate c...
Prostate cancer (PCa) is the most common malignancy in men worldwide, leading to substantial morbidi...
68Gallium prostate specific membrane antigen (PSMA) ligand positron emission tomography (PET) is an ...
Nowadays several new imaging modalities are available for investigating prostate cancer (PCa) such a...
Prostate-specific membrane antigen (PSMA) positron emission tomography/magnetic resonance imaging (P...
Abstract 68Gallium prostate specific membrane antigen (PSMA) ligand positron emission tomography (PE...
Imaging has a central role in the context of focal therapy (FT) for prostate cancer (PCa). Prostate-...
Positron emission tomography (PET) has been commonly and successfully used, in combination with comp...
OBJECTIVE: The purpose of this article is to describe the large number of radiotracers being evalu...
Prospective evidence for the clinical role and efficacy of prostate specific membrane antigen (PSMA)...
Positron emission tomography (PET) has been commonly and successfully used, in combination with comp...
IntroductionProstate-specific membrane antigen (PSMA) is increasingly being recognized as a novel ta...
Gallium-68 and Fluor-18 labeled prostate specific membrane antigen (PSMA) molecules have created new...